litlas
Log inCreate account

George N. Thalmann

Active 1994–2026

118
Papers
23,898
Citations
84
h-index
115
i10-index

Citations

Citations per year for George N. Thalmann1995: 2 citations1996: 9 citations1997: 4 citations1998: 14 citations1999: 18 citations2000: 21 citations2001: 30 citations2002: 20 citations2003: 65 citations2004: 50 citations2005: 61 citations2006: 75 citations2007: 96 citations2008: 71 citations2009: 86 citations2010: 92 citations2011: 131 citations2012: 110 citations2013: 128 citations2014: 113 citations2015: 116 citations2016: 130 citations2017: 166 citations2018: 170 citations2019: 665 citations2020: 686 citations2021: 763 citations2022: 596 citations2023: 486 citations2024: 897 citations2025: 363 citations2026: 12 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,128 citing papers, 21% of this breakdownChina: 942 citing papers, 9.3% of this breakdownUnited Kingdom: 674 citing papers, 6.6% of this breakdownGermany: 669 citing papers, 6.6% of this breakdownItaly: 668 citing papers, 6.6% of this breakdownCanada: 459 citing papers, 4.5% of this breakdownSwitzerland: 424 citing papers, 4.2% of this breakdownFrance: 409 citing papers, 4% of this breakdownNetherlands: 395 citing papers, 3.9% of this breakdownJapan: 296 citing papers, 2.9% of this breakdownSpain: 292 citing papers, 2.9% of this breakdownAustralia: 280 citing papers, 2.8% of this breakdown
0%21%Other 24.7%

Institutions

Fields

  • Medicine78.7%
  • Biochemistry, Genetics and Molecular Biology15.8%
  • Immunology and Microbiology2%
  • Engineering1.1%
  • Neuroscience0.4%
  • Mathematics0.3%
  • Other1.7%

Topics

  • Bladder and Urothelial Cancer Treatments11.5%
  • Prostate Cancer Treatment and Research10%
  • Prostate Cancer Diagnosis and Treatment7.2%
  • Urinary and Genital Oncology Studies6.2%
  • Cancer Cells and Metastasis2.6%
  • Radiopharmaceutical Chemistry and Applications2.3%
  • Other60.2%

Coauthors

All papers

Open in search
  1. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines

    Authors: J. Alfred Witjes, Harman Max Bruins, Richard Cathomas, Éva Compérat, Nigel C. Cowan, Georgios Gakis, Virginia Hernández, Estefania Linares Espinós, Anja Lorch, Y. Neuzillet, Mathieu Rouanne, George N. Thalmann, Erik Veskimäe, María J. Ribal, Antoine G. van der Heijden - European Urology 2020 cited by 2,145

  2. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines

    Authors: J. Alfred Witjes, Harman Max Bruins, Albert Carrión, Richard Cathomas, Éva Compérat, Jason A. Efstathiou, Rainer Fietkau, Georgios Gakis, Anja Lorch, Alberto Martini, Laura S. Mertens, Richard P. Meijer, Matthew I. Milowsky, Y. Neuzillet, Valeria Panebianco, John Redlef, Michael Rink, Mathieu Rouanne, George N. Thalmann, Sæbjørn Sæbjørnsen, Erik Veskimäe, Antoine G. van der Heijden - European Urology 2023 cited by 625

  3. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

    Authors: Nicholas D. James, Matthew R. Sydes, Noel W. Clarke, Malcolm D. Mason, David P. Dearnaley, Melissa Spears, A.W.S. Ritchie, Christopher Parker, John M. Russell, Gerhardt Attard, Johann S. de Bono, William Cross, Robert J. Jones, George N. Thalmann, Claire Amos, David Matheson, Robin Millman, Mymoona Alzouebi, S. Beesley, Alison Birtle, Susannah Brock, Richard Cathomas, Prabir Chakraborti, Simon Chowdhury, Audrey Cook, Tony Elliott, Joanna Gale, Stephanie Gibbs, John D. Graham, John Hetherington, Robert Hughes, Robert Laing, Fiona McKinna, Duncan B. McLaren, Joe M. O’Sullivan, Omi Parikh, C. Peedell, Andrew Protheroe, Angus Robinson, Narayanan Srihari, Rajaguru Srinivasan, John Staffurth, Santhanam Sundar, Shaun Tolan, David Tsang, John Wagstaff, Mahesh Parmar - The Lancet 2015 cited by 1,968

  4. Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial

    Authors: Christopher Parker, Nicholas D. James, Chris Brawley, Noel W. Clarke, Alex Hoyle, Adnan Ali, A.W.S. Ritchie, Gerhardt Attard, Simon Chowdhury, William Cross, David P. Dearnaley, Silke Gillessen, Clare Gilson, Robert J. Jones, Ruth E. Langley, Zafar Malik, Malcolm D. Mason, David Matheson, Robin Millman, John M. Russell, George N. Thalmann, Claire Amos, Roberto Alonzi, Amit Bahl, Alison Birtle, Omar Din, Hassan Douis, Chinnamani Eswar, Joanna Gale, Melissa Gannon, Sai Jonnada, Sara Khaksar, J.F. Lester, Joe M. O’Sullivan, Omi Parikh, Ian Pedley, Delia Pudney, D.J. Sheehan, Narayanan Srihari, Anna Tran, Mahesh Parmar, Matthew R. Sydes - The Lancet 2018 cited by 1,262

  5. The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma

    Authors: Richard Cathomas, Anja Lorch, Harman Max Bruins, Éva Compérat, Nigel C. Cowan, Jason A. Efstathiou, Rainer Fietkau, Georgios Gakis, Virginia Hernández, Estefania Linares Espinós, Y. Neuzillet, María J. Ribal, Mathieu Rouanne, George N. Thalmann, Antoine G. van der Heijden, Erik Veskimäe, J. Alfred Witjes, Matthew I. Milowsky - European Urology 2021 cited by 296

  6. Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy

    Authors: Roland Seiler, H.A.D.M. Ashab, Nicholas Erho, Bas W.G. van Rhijn, Brian Winters, James J. Douglas, Kim E. van Kessel, Elisabeth E. Fransen van de Putte, Matthew Sommerlad, Natalie Q. Wang, Voleak Choeurng, Ewan A. Gibb, Beatrix Palmer-Aronsten, Lucia L.C. Lam, Christine Buerki, Elai Davicioni, Gottfrid Sjödahl, Jordan Kardos, Katherine A. Hoadley, Seth P. Lerner, David J. McConkey, Woonyoung Choi, William Y. Kim, Bernhard Kiss, George N. Thalmann, Tilman Todenhöfer, Simon J. Crabb, Scott North, Ellen C. Zwarthoff, Joost L. Boormans, Jonathan L. Wright, Marc Dall’Era, Michiel S. van der Heijden, Peter C. Black - European Urology 2017 cited by 792

  7. Patient-derived xenografts and organoids model therapy response in prostate cancer

    Authors: Sofia Karkampouna, Federico La Manna, Andrej Benjak, Mirjam Kiener, Marta De Menna, Eugenio Zoni, Joël Grosjean, Irena Klima, Andrea Garofoli, Marco Bolis, Arianna Vallerga, Jean‐Philippe Theurillat, Maria Rosaria De Filippo, Vera Genitsch, David Keller, Tijmen H. Booij, Christian U. Stirnimann, Kenneth Eng, Andrea Sboner, Charlotte K.Y. Ng, Salvatore Piscuoglio, Peter C. Gray, Martin Spahn, Mark A. Rubin, George N. Thalmann, Marianna Kruithof‐de Julio - Nature Communications 2021 cited by 154

  8. Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancer

    Authors: Juening Kang, Federico La Manna, Francesco Bonollo, Natalie Sampson, Ian Alberts, Clemens Mingels, Ali Afshar‐Oromieh, George N. Thalmann, Sofia Karkampouna - Cancer Letters 2022 cited by 164

  9. Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)

    Authors: Francesco Soria, Shahrokh F. Shariat, Seth P. Lerner, Hans‐Martin Fritsche, Michael Rink, Wassim Kassouf, Philippe E. Spiess, Yair Lotan, Dingwei Ye, Mario I. Fernández, Eiji Kikuchi, Daher Chade, Marko Babjuk, Arthur P. Grollman, George N. Thalmann - World Journal of Urology 2016 cited by 472

  10. The Role of Cancer-Associated Fibroblasts in Prostate Cancer Tumorigenesis

    Authors: Francesco Bonollo, George N. Thalmann, Marianna Kruithof‐de Julio, Sofia Karkampouna - Cancers 2020 cited by 176

  11. Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression

    Authors: Marco Bolis, Daniela Bossi, Arianna Vallerga, Valentina Ceserani, Manuela Cavalli, Daniela Impellizzieri, Laura Di Rito, Eugenio Zoni, Simone Mosole, Angela Rita Elia, Andrea Rinaldi, Ricardo Pereira Mestre, Eugenia D’Antonio, Matteo Ferrari, Flavio Stoffel, Fernando Jermini, Silke Gillessen, Lukas Bubendorf, Peter Schraml, Arianna Calcinotto, Eva Corey, Holger Moch, Martin Spahn, George N. Thalmann, Marianna Kruithof‐de Julio, Mark A. Rubin, Jean‐Philippe Theurillat - Nature Communications 2021 cited by 110

  12. Bladder cancer organoids as a functional system to model different disease stages and therapy response

    Authors: Martina Minoli, Thomas Cantore, Daniel Hanhart, Mirjam Kiener, Tarcisio Fedrizzi, Federico La Manna, Sofia Karkampouna, Panagiotis Chouvardas, Vera Genitsch, Antonio Rodríguez-Calero, Éva Compérat, Irena Klima, Paola Gasperini, Bernhard Kiss, Roland Seiler, Francesca Demichelis, George N. Thalmann, Marianna Kruithof‐de Julio - Nature Communications 2023 cited by 98

  13. Her2 Amplification is Significantly More Frequent in Lymph Node Metastases From Urothelial Bladder Cancer Than in the Primary Tumours

    Authors: Achim Fleischmann, Diana Rotzer, Roland Seiler, Urs E. Studer, George N. Thalmann - European Urology 2011 cited by 181

  14. Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial

    Authors: Cora N. Sternberg, Iwona Skoneczna, J. Martijn Kerst, Peter Albers, Sophie D. Fosså, Mads Agerbæk, Herlinde Dumez, Maria De Santis, Christine Théodore, Michael Leahy, John Chester, A. Verbaeys, Gedske Daugaard, Lori Wood, J. Alfred Witjes, Ronald de Wit, L. Geoffrois, Lisa Sengeløv, George N. Thalmann, Danielle Charpentier, Frédéric Rolland, L. Mignot, Santhanam Sundar, Paul Symonds, John D. Graham, Florence Joly, Sandrine Marréaud, Laurence Collette, Richard Sylvester - The Lancet Oncology 2014 cited by 387

  15. Preexisting BCG-Specific T Cells Improve Intravesical Immunotherapy for Bladder Cancer

    Authors: Claire Biot, Cyrill A. Rentsch, Joël Gsponer, Frédéric D. Birkhäuser, Hélène Jusforgues-Saklani, Fabrice Lemaı̂tre, Charlotte Auriau, Alexander Bachmann, Philippe Bousso, Caroline Demangel, Lucie Peduto, George N. Thalmann, Matthew L. Albert - Science Translational Medicine 2012 cited by 270

  16. A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non–muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14

    Authors: Cyrill A. Rentsch, George N. Thalmann, Ilaria Lucca, Maciej Kwiatkowski, Grégory J. Wirth, Räto T. Strebel, Daniel Engeler, A Pedrazzini, Clemens Hüttenbrink, Wolfgang Schultze‐Seemann, Raimund Torpai, Lukas Bubendorf, Andreas Wicki, Beat Roth, Piet Bosshard, Heike Püschel, Daniel T. Boll, Lukas J. Hefermehl, Florian Roghmann, Michael Gierth, Karin Ribi, Simon Schäfer, Stefanie Hayoz - European Urology Oncology 2022 cited by 38

  17. An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancer

    Authors: George van Andel, Andrew Bottomley, Sophie D. Fosså, Fabio Efficace, Corneel Coens, S. Guérif, Howard Kynaston, Paolo Gontero, George N. Thalmann, A. Akdaş, Sven D’haese, Neil K. Aaronson - European Journal of Cancer 2008 cited by 485

  18. Survival with Newly Diagnosed Metastatic Prostate Cancer in the “Docetaxel Era”: Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)

    Authors: Nicholas D. James, Melissa Spears, Noel W. Clarke, David P. Dearnaley, Johann S. de Bono, Joanna Gale, John Hetherington, Peter Hoskin, Robert J. Jones, Robert Laing, J.F. Lester, Duncan B. McLaren, Christopher Parker, Mahesh Parmar, A.W.S. Ritchie, John M. Russell, Räto T. Strebel, George N. Thalmann, Malcolm D. Mason, Matthew R. Sydes - European Urology 2014 cited by 436

  19. Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review

    Authors: Guillaume Ploussard, Siamak Daneshmand, Jason A. Efstathiou, Harry W. Herr, Nicholas D. James, Claus Rödel, Shahrokh F. Shariat, William U. Shipley, Cora N. Sternberg, George N. Thalmann, Wassim Kassouf - European Urology 2014 cited by 358

  20. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines

    Authors: Antoine G. van der Heijden, Harman Max Bruins, Albert Carrión, Richard Cathomas, Éva Compérat, Konstantinos Dimitropoulos, Jason A. Efstathiou, Rainer Fietkau, Mithun Kailavasan, Anja Lorch, Alberto Martini, Laura S. Mertens, Richard P. Meijer, Param Mariappan, Matthew I. Milowsky, Y. Neuzillet, Valeria Panebianco, Sæbjørn Sæbjørnsen, Emma Jane Smith, George N. Thalmann, Michael Rink - European Urology 2025 cited by 164

  21. Impact of Pelvic Lymph Node Dissection and Its Extent on Perioperative Morbidity in Patients Undergoing Radical Prostatectomy for Prostate Cancer: A Comprehensive Systematic Review and Meta-analysis

    Authors: Giovanni Cacciamani, Marissa Maas, Nima Nassiri, David G. Ortega, Karanvir Gill, Paolo Dell’Oglio, George N. Thalmann, Axel Heidenreich, James A. Eastham, Christopher P. Evans, R. Jeffrey Karnes, Andre Luis Abreu, Alberto Briganti, Walter Artibani, Inderbir S. Gill, Francesco Montorsi - European Urology Oncology 2021 cited by 130

  22. Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer

    Authors: Roland Seiler, Ewan A. Gibb, Natalie Q. Wang, Htoo Zarni Oo, Hung‐Ming Lam, Kim E. van Kessel, Charlotte S. Voskuilen, Brian Winters, Nicholas Erho, Mandeep Takhar, James J. Douglas, Funda Vakar‐Lopez, Simon J. Crabb, Bas W.G. van Rhijn, Elisabeth E. Fransen van de Putte, Ellen C. Zwarthoff, George N. Thalmann, Elai Davicioni, Joost L. Boormans, Marc Dall’Era, Michiel S. van der Heijden, Jonathan L. Wright, Peter C. Black - Clinical Cancer Research 2018 cited by 126

  23. Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapy

    Authors: Bernhard Kiss, Alexander W. Wyatt, James J. Douglas, Veronika Skuginna, Fan Mo, Shawn Anderson, Diana Rotzer, Achim Fleischmann, Vera Genitsch, Tetsutaro Hayashi, Maja Neuenschwander, Christine Buerki, Elai Davicioni, Colin C. Collins, George N. Thalmann, Peter C. Black, Roland Seiler - Scientific Reports 2017 cited by 115

  24. Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial

    Authors: Pirus Ghadjar, Stefanie Hayoz, Jürg Bernhard, Daniel R. Zwahlen, Tobias Hölscher, Philipp Gut, Bülent Polat, Guido Hildebrandt, Arndt‐Christian Müller, Ludwig Plaßwilm, Alexandros Papachristofilou, Corinne Schär, Marcin Sumila, Kathrin Zaugg, Matthias Gückenberger, Piet Ost, Christiane Reuter, Davide Giovanni Bosetti, Kaouthar Khanfir, Silvia Gómez, Peter Wust, George N. Thalmann, Daniel M. Aebersold, P. Gut, P. Thum, J. Collon, P.M. Putora, L. Plasswilm, M. Sassowsky, G.N. Thalmann, D.M. Aebersold, M. Sumila, H. Kranzbühler, K. Zaugg, A. Papachristofilou, F. Zimmermann, Y. Najafi, M. Brown, M. Guckenberger, S. Wuttke, C. Reuter, C. Oehler, D.R. Zwahlen, N.C. Azinwi, D.G. Bosetti, G. Pesce, I. Tacacs, S. Bodis, S. Gomez, K. Khanfir, F. Behrensmeier, K. Beer, P. Messer, T. Hölscher, M. Baumann, B. Polat, M. Flentje, V. Lewitzki, G. Hildebrandt, A.C. Müller, D. Zips, P. Ghadjar, P. Wust, V. Budach, U. Ganswindt, C. Belka, M. Pinkawa, M.J. Eble, K. Berkovic, M. Stuschke, P. Ost, F. Vandaele - European Urology 2021 cited by 113